Tofisopam - Wikipedia
WEBTofisopam is indicated for the treatment of anxiety and alcohol withdrawal, and is prescribed in a dosage of 50–300 mg per day divided into three doses. Peak plasma levels are attained two hours after an oral dose.
Tofisopam: Uses & Characteristics Of This Atypical Benzodiazepine
WEBJan 18, 2024 · Tofisopam is indicated for the short-term management of anxiety and the relief of alcohol withdrawal syndrome. It’s being explored as a potential treatment for neurodegenerative disorders, including Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS).
Tofisopam: Uses, Interactions, Mechanism of Action | DrugBank …
WEBJan 20, 2011 · Tofisopam (marketed under brand names Emandaxin and Grandaxin) is a 2,3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from …
The atypical anxiolytic drug, tofisopam, selectively blocks ...
WEBOct 22, 2010 · Tofisopam, a 2,3-benzodiazepine (2,3-BDZs), represent a unique drug among CNS-active compounds. Though sharing a common chemical backbone to ‘classical’ 1,4-benzodiazepines and though sharing the anxiolytic activity, the compound does not interact with the benzodiazepine binding site of the γ-aminobutyric acid (GABA) receptor …
Tofisopam - an overview | ScienceDirect Topics
WEBTofisopam. A benzodiazepine traditionally indicated for use as an anxiolytic drug, tofisopam is a medication that historically was not associated with gout therapy.
‘New/Designer Benzodiazepines’: An Analysis of the Literature and ...
WEBTofisopam is a BZD first developed in Hungary and authorised in some European countries, marketed in the racemate form under the name Grandaxin ®, orally administered at 300 mg daily for the treatment of neurotic and somatic disorders associated with tension, anxiety, vegetative disorders, lack of energy and motivation, apathy, fatigue ...
A Comparison of the Anxiolytic Properties of Tofisopam and
WEBJan 22, 2024 · 1. Introduction. Tofisopam belongs to the class of 2,3-benzodiazepines. It has been approved and used as one of numerous benzodiazepines in several countries, including France, Hungary, Lithuania, Latvia, the Czech Republic, and Slovakia in the European Union, as well as Japan, Argentina (since the 1970s), and recently, India [ 1 ].
Role of Tofisopam in Post COVID Neuro-psychiatric Sequelae: A …
WEBFeb 26, 2021 · Tofisopam has an anxiolytic effect in anxiety and depression, without sedative and muscle relaxant side-effects, has anti-amnestic properties, and works for both positive and negative symptoms of psychosis.
Tofisopam - Wikiwand
WEBTofisopam is indicated for the treatment of anxiety and alcohol withdrawal, and is prescribed in a dosage of 50–300 mg per day divided into three doses. Peak plasma levels are attained two hours after an oral dose.
The atypical anxiolytic drug, tofisopam, selectively blocks
WEBOct 22, 2010 · Tofisopam, a 2,3-benzodiazepine (2,3-BDZs), represent a unique drug among CNS-active compounds. Though sharing a common chemical backbone to ‘classical’ 1,4-benzodiazepines and though sharing the anxiolytic activity, the compound does not interact with the benzodiazepine binding site of the γ-aminobutyric acid (GABA) receptor …
- Some results have been removed
Skip to content